Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas D Vallois, MPD Dobay, RD Morin, F Lemonnier, E Missiaglia, M Juilland, ... Blood, The Journal of the American Society of Hematology 128 (11), 1490-1502, 2016 | 336 | 2016 |
Comprehensive mutational profiling of core binding factor acute myeloid leukemia N Duployez, A Marceau-Renaut, N Boissel, A Petit, M Bucci, S Geffroy, ... Blood, The Journal of the American Society of Hematology 127 (20), 2451-2459, 2016 | 278 | 2016 |
Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study S Dubois, PJ Viailly, S Mareschal, E Bohers, P Bertrand, P Ruminy, ... Clinical cancer research 22 (12), 2919-2928, 2016 | 239 | 2016 |
Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology K Belarbi, S Burnouf, FJ Fernandez-Gomez, C Laurent, S Lestavel, ... Neurobiology of disease 43 (2), 486-494, 2011 | 206 | 2011 |
Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations JB Micol, N Duployez, N Boissel, A Petit, S Geffroy, O Nibourel, ... Blood, The Journal of the American Society of Hematology 124 (9), 1445-1449, 2014 | 144 | 2014 |
Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells AF Dessein, L Stechly, N Jonckheere, P Dumont, D Monté, E Leteurtre, ... Cancer research 70 (11), 4644-4654, 2010 | 141 | 2010 |
Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P–mutated diffuse large B-cell lymphoma: analysis of 361 cases S Dubois, PJ Viailly, E Bohers, P Bertrand, P Ruminy, V Marchand, ... Clinical Cancer Research 23 (9), 2232-2244, 2017 | 130 | 2017 |
Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia S Poulain, C Roumier, A Venet-Caillault, M Figeac, C Herbaux, G Marot, ... Clinical Cancer Research 22 (6), 1480-1488, 2016 | 128 | 2016 |
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association H Debarri, D Lebon, C Roumier, M Cheok, A Marceau-Renaut, O Nibourel, ... Oncotarget 6 (39), 42345, 2015 | 121 | 2015 |
Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma F Jardin, A Pujals, L Pelletier, E Bohers, V Camus, S Mareschal, S Dubois, ... American journal of hematology 91 (9), 923-930, 2016 | 117 | 2016 |
Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease E Faivre, JE Coelho, K Zornbach, E Malik, Y Baqi, M Schneider, L Cellai, ... Frontiers in molecular neuroscience 11, 235, 2018 | 90 | 2018 |
BAP1 is altered by copy number loss, mutation, and/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas N Leblay, F Leprêtre, N Le Stang, A Gautier-Stein, L Villeneuve, S Isaac, ... Journal of Thoracic Oncology 12 (4), 724-733, 2017 | 90 | 2017 |
Accurate classification of germinal center B-cell–like/activated B-cell–like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase–multiplex ligation … S Mareschal, P Ruminy, C Bagacean, V Marchand, M Cornic, JP Jais, ... The Journal of Molecular Diagnostics 17 (3), 273-283, 2015 | 85 | 2015 |
Fast multiclonal clusterization of V (D) J recombinations from high-throughput sequencing M Giraud, M Salson, M Duez, C Villenet, S Quief, A Caillault, N Grardel, ... BMC genomics 15, 1-12, 2014 | 80 | 2014 |
Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease A Keo, A Mahfouz, AMT Ingrassia, JP Meneboo, C Villenet, E Mutez, ... Communications biology 3 (1), 101, 2020 | 78 | 2020 |
Dominance hierarchy arising from the evolution of a complex small RNA regulatory network E Durand, R Méheust, M Soucaze, PM Goubet, S Gallina, C Poux, ... Science 346 (6214), 1200-1205, 2014 | 74 | 2014 |
Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease E Mutez, A Nkiliza, K Belarbi, A de Broucker, C Vanbesien-Mailliot, ... Neurobiology of disease 63, 165-170, 2014 | 71 | 2014 |
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+ CD56+ haematodermic neoplasms and contribute … F Jardin, M Callanan, D Penther, P Ruminy, X Troussard, JP Kerckaert, ... Leukemia 23 (4), 698-707, 2009 | 71 | 2009 |
Nail–Patella Syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity J Ghoumid, F Petit, M Holder-Espinasse, AS Jourdain, J Guerra, ... European Journal of Human Genetics 24 (1), 44-50, 2016 | 66 | 2016 |
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia. JE Bibault, M Figeac, N Hélevaut, C Rodriguez, S Quief, S Sebda, ... Oncotarget 6 (26), 22812-22821, 2015 | 63 | 2015 |